SOAT1 and acute lymphoblastic leukemia: We compared the transcriptional profile of patients with and without JAK/STAT pathway mutations and, specifically, we evaluated the activation status of several signaling pathways that are recurrently deregulated in T-ALL/LBL and whose deregulation may contribute to tumor development (Fig. 1b).